Interaction of phenylbutazone and colchicine in binding to serum albumin in rheumatoid therapy: 1H NMR study.
The monitoring of drug concentration in blood serum is necessary in multi-drug therapy. Mechanism of drug binding with serum albumin (SA) is one of the most important factors which determine drug concentration and its transport to the destination tissues. In rheumatoid diseases drugs which can induce various adverse effects are commonly used in combination therapy. Such proceeding may result in the enhancement of those side effects due to drug interaction. Interaction of phenylbutazone and colchicine in binding to serum albumin and competition between them in gout has been studied by proton nuclear magnetic resonance ((1)H NMR) technique. The aim of the study was to determine the low affinity binding sites, the strength and kind of interaction between serum albumin and drugs used in combination therapy. The study of competition between phenylbutazone and colchicine in binding to serum albumin points to the change of their affinity to serum albumin in the ternary systems. This should be taken into account in multi-drug therapy. This work is a subsequent part of the spectroscopic study on Phe-COL-SA interactions [A. Sułkowska, et al., J. Mol. Struct. 881 (2008) 97-106].
Maciazek-Jurczyk
M
M
Department of Physical Pharmacy, Faculty of Pharmacy, Medical University of Silesia, Jagiellońska 4, 41-200 Sosnowiec, Poland.
Sułkowska
A
A
Bojko
B
B
Równicka-Zubik
J
J
Sułkowski
W W
WW
D000893:Anti-Inflammatory Agents / Q000008:administration & dosage / Q000378:metabolism / Q000494:pharmacology; D003078:Colchicine / Q000008:administration & dosage* / Q000378:metabolism* / Q000494:pharmacology; D004338:Drug Combinations; D004347:Drug Interactions; D006801:Humans; D008279:Magnetic Resonance Imaging / Q000379:methods; D008954:Models, Biological; D010653:Phenylbutazone / Q000008:administration & dosage* / Q000378:metabolism* / Q000494:pharmacology; D011485:Protein Binding / Q000187:drug effects; D011522:Protons; D012216:Rheumatic Diseases / Q000097:blood / Q000188:drug therapy* / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism*
D000893:Anti-Inflammatory Agents; D004338:Drug Combinations; D011522:Protons; D012709:Serum Albumin; D010653:Phenylbutazone; D003078:Colchicine